Benchling
We're Hiring!
Benchling Company Growth, Stability & Outlook
What People Are Saying About Benchling
-
Strong Revenue Growth: ARR was estimated around $200M+ by mid-2024 with year-over-year increases, alongside a larger customer base and higher revenue per customer. These signals indicate ongoing expansion in core subscription economics.
-
Strategic Partnerships: An expanded collaboration with Moderna bringing hundreds of scientists onto a unified, AI-ready environment signals deepening penetration in large biopharma accounts. Such marquee expansions reinforce credibility and create room for further account growth.
-
Product Line Growth: The company has shipped frequent platform updates, launched AI capabilities, and integrated partners like NVIDIA NIM, while adding offerings such as Benchling Bioprocess and via the PipeBio acquisition. This broadens the product surface area and supports land-and-expand motions.
